Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ross Coomber

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Harm Reduction Journal|July 4, 2025
Anabolic-androgenic steroid testing as a tool for consumer engagement and harm reduction: a sequential explanatory mixed-method studyTimothy Piatkowski, Ross Coomber, Cameron Francis, et al.
International Clinical Psychopharmacology|July 8, 2024
Assessment of clinical outcomes in patients with inflammatory arthritis: analysis from the UK Medical Cannabis RegistryAnn Francis, Simon Erridge, Carl Holvey, et al.
Journal of Cannabis Research|January 4, 2022
UK Medical Cannabis Registry palliative care patients cohort: initial experience and outcomesDevaki Nimalan, Michal Kawka, Simon Erridge, et al.
Pain Practice : the Official Journal of World Institute of Pain|November 15, 2024
UK medical cannabis registry: A clinical outcome analysis of medical cannabis therapy in chronic pain patients with and without co-morbid sleep impairmentIshita Datta, Simon Erridge, Carl Holvey, et al.
International Clinical Psychopharmacology|February 1, 2024
UK Medical Cannabis Registry: a case series analyzing clinical outcomes of medical cannabis therapy for generalized anxiety disorder patientsAdam Li, Simon Erridge, Carl Holvey, et al.
Drug and Alcohol Review|February 11, 2025
Development, dissemination and community response towards the first community notice regarding misrepresented illicit anabolic-androgenic steroids in circulation in AustraliaTimothy Piatkowski, Isabelle Volpe, Rita Brien, et al.
Psychopharmacology|June 14, 2023
Clinical outcome data of anxiety patients treated with cannabis-based medicinal products in the United Kingdom: a cohort study from the UK Medical Cannabis RegistryRaphael Rifkin-Zybutz, Simon Erridge, Carl Holvey, et al.
The International Journal on Drug Policy|June 12, 2018
The burgeoning recognition and accommodation of the social supply of drugs in international criminal justice systems: An eleven-nation comparative overviewRoss Coomber, Leah Moyle, Vendula Belackova, et al.
Neuropsychopharmacology Reports|May 14, 2021
An initial analysis of the UK Medical Cannabis Registry: Outcomes analysis of first 129 patientsSimon Erridge, Oliver Salazar, Michal Kawka, et al.
Expert Review of Neurotherapeutics|December 12, 2022
Assessment of clinical outcomes in patients with post-traumatic stress disorder: analysis from the UK Medical Cannabis RegistryManaswini Pillai, Simon Erridge, Lara Bapir, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Harm Reduction Journal|July 4, 2025
Anabolic-androgenic steroid testing as a tool for consumer engagement and harm reduction: a sequential explanatory mixed-method studyTimothy Piatkowski, Ross Coomber, Cameron Francis, et al.
International Clinical Psychopharmacology|July 8, 2024
Assessment of clinical outcomes in patients with inflammatory arthritis: analysis from the UK Medical Cannabis RegistryAnn Francis, Simon Erridge, Carl Holvey, et al.
Journal of Cannabis Research|January 4, 2022
UK Medical Cannabis Registry palliative care patients cohort: initial experience and outcomesDevaki Nimalan, Michal Kawka, Simon Erridge, et al.
Pain Practice : the Official Journal of World Institute of Pain|November 15, 2024
UK medical cannabis registry: A clinical outcome analysis of medical cannabis therapy in chronic pain patients with and without co-morbid sleep impairmentIshita Datta, Simon Erridge, Carl Holvey, et al.
International Clinical Psychopharmacology|February 1, 2024
UK Medical Cannabis Registry: a case series analyzing clinical outcomes of medical cannabis therapy for generalized anxiety disorder patientsAdam Li, Simon Erridge, Carl Holvey, et al.
Drug and Alcohol Review|February 11, 2025
Development, dissemination and community response towards the first community notice regarding misrepresented illicit anabolic-androgenic steroids in circulation in AustraliaTimothy Piatkowski, Isabelle Volpe, Rita Brien, et al.
Psychopharmacology|June 14, 2023
Clinical outcome data of anxiety patients treated with cannabis-based medicinal products in the United Kingdom: a cohort study from the UK Medical Cannabis RegistryRaphael Rifkin-Zybutz, Simon Erridge, Carl Holvey, et al.
The International Journal on Drug Policy|June 12, 2018
The burgeoning recognition and accommodation of the social supply of drugs in international criminal justice systems: An eleven-nation comparative overviewRoss Coomber, Leah Moyle, Vendula Belackova, et al.
Neuropsychopharmacology Reports|May 14, 2021
An initial analysis of the UK Medical Cannabis Registry: Outcomes analysis of first 129 patientsSimon Erridge, Oliver Salazar, Michal Kawka, et al.
Expert Review of Neurotherapeutics|December 12, 2022
Assessment of clinical outcomes in patients with post-traumatic stress disorder: analysis from the UK Medical Cannabis RegistryManaswini Pillai, Simon Erridge, Lara Bapir, et al.
Pageof 9